YouTube on MSN
Who are the Grey Company?
Explore the best of fantasy and sci-fi in depth, with analysis of the worlds of Lord of the Rings, Game of Thrones, The ...
YouTube on MSN
What actually are Dragon Dreams?
Explore the best of fantasy and sci-fi in deep, geeky detail, with analysis of the worlds of Lord of the Rings, Game of ...
Rock and extreme music fans can rejoice! Re-Animator is making its comeback to Brittany. Mark your calendars for Thursday, ...
Scientists once thought that planning required a primate brain. Experiments with birds are now proving that assumption wrong.
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
Corvus Pharmaceuticals (CRVS) jumped ~66% in the premarket on Tuesday after the clinical-stage biotech announced plans to initiate a mid-stage trial for its lead asset, soquelitinib, for a skin ...
Corvus Pharmaceuticals Inc. (CRVS) priced an underwritten public offering of 7,900,677 shares of common stock at $22.15 per ...
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Get the detailed quarterly/annual income statement for Corvus Pharmaceuticals, Inc. (CRVS). Find out the revenue, expenses and profit or loss over the last fiscal year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results